• Basket
  • Log in

Join
today

Boliven PRO is more than just patent search

  • Build and save lists using the powerful Lists feature
  • Analyze and download your search results
  • Share patent search results with your clients

New to Patents? Find out more from CambridgeIP ®

Patents »

US5561107: Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides

Share

Share on Linked In Share on Facebook Share by Email

Filing Information

Inventor(s) Jesse M. Jaynes · Gordon R. Julian ·
Assignee(s) Demeter Biotechnologies, Ltd. ·
Attorney/Agent(s) Rothwell, Figg, Ernst & Kurz ·
Primary Examiner Jeffrey E. Russel ·
Application Number US8231730
Filing date 04/20/1994
Issue date 10/01/1996
Predicted expiration date 06/04/2013
U.S. Classifications 514/12  · 514/13  ·
International Classifications A61K 3810  ·
Kind CodeA
International Classifications 530324;325;326;327;345 ·
Related U.S. Application DataCROSS-REFERENCE TO RELATED APPLICATIONS
This is a continuation-in-part of U.S. patent application Ser. No. 08/225,476 filed Apr. 8, 1994 in the names of Jesse M. Jaynes and Gordon R. Julian for "METHOD OF COMBATTING MAMMALIAN NEOPLASIA, AND LYTIC PEPTIDES THEREFOR", now abandoned, which in turn is a continuation-in-part of 08/039,620 filed Jun. 4, 1993 in the names of Jesse M. Jaynes and Gordon R. Julian, now abandoned, and is also a continuation-in-part of U.S. patent application Ser. No. 08/148,889 filed Nov. 8, 1993 in the name of Gordon R. Julian, now abandoned, as well as a continuation-in-part of U.S. patent application Ser. No. 08/148,491 filed Nov. 8, 1993 in the name of Gordon R. Julian, now abandoned.
13 Claims, No Drawings


Abstract

A method of treating a wound of a mammalian subject in need of such treatment, to promote healing thereof, comprising administering to the subject, e.g., to the wound locus, a composition comprising a fibroblast and keratinocyte proliferatingly effective amount of an amphipathic peptide, preferably an amphipathic peptide which is antimicrobially effective at such locus. A method is also disclosed of stimulating the accelerated growth of dermal tissue in a tissue culture containing same, comprising applying to the tissue culture a fibroblast and keratinocyte proliferatingly effective amount of an amphipathic peptide, by which the dermal tissue may be grown to produce skin for skin grafting purposes, utilizing a dermal tissue culture containing dermal tissue material of a skin graft recipient of such skin. Novel amphipathic peptides suitable for use in such methods are disclosed.

Independent Claims | See all claims (13)

  1. 1. A method of stimulating the accelerated growth of dermal tissue in a tissue culture containing the same, comprising applying to the tissue culture a fibroblast and keratinocyte proliferatingly effective amount of an amphipathic peptide having a sequence selected from the group consistinq of SEQ ID NOs. 41 to 46.
  2. 2. A method of promoting wound healing in a mammalian subject having a wound in need of treatment comprising administering to said subject a composition of a fibroblast and keratinocyte proliferatingly effective amount of an amphipathic peptide, wherein the amphipathic peptide comprises a peptide having a sequence selected from SEQ ID NOs. 41 to 46.
  3. 3. A method of promoting wound healing in a mammalian subject having a wound in need of treatment comprising administering to said subject a composition of a fibroblast and keratinocyte proliferatingly effective amount of an amphipathic peptide of a sequence selected from SEQ ID NOs. 41 to 46, wherein the amphipathic peptides has been modified to provide enhanced proteolytic resistance to the peptide.
  4. 11. An amphipathic peptide comprising a peptide having a sequence selected from SEQ ID NOs. 41 to 46.

References Cited

U.S. Patent Documents

Document NumberAssigneesInventorsIssue/Pub Date
US4355104 Kabigen AB Hultmark et al. Oct 1982
US4520016 KabiGen AB Hultmark et al. May 1985
US4810777 The United States of America as represented by the Department of Health and Human Services Zasloff Mar 1989
US4940666 University Patents, Inc. Boyce et al. Jul 1990
US5045531 Magainin Sciences Inc. Berkowitz et al. Sep 1991
US5070188 Ethicon, Inc. Njieha et al. Dec 1991
US5186166 RIGGS JOHN H Riggs et al. Feb 1993
US5242902 The Regents of the University of California Murphy et al. Sep 1993
US5294605 The Scripps Research Institute Houghten et al. Mar 1994
US5411942 Carlbiotech Ltd. A/S Widmer et al. May 1995
US5424290 Magainin Pharmaceuticals Inc. Maloy et al. May 1995

Foreign Patent Documents

Document NumberAssigneesInventorsIssue/Pub Date
CA2047317SCRIPPS RESEARCH INSTJan 1992
WO2012866Nov 1990

Other Publications

Biochemistry, vol. 7, No. 6, issued Jun. 1968, Means et al, "Reductive Alkylation of Amino Groups in Proteins", pp. 2192-2201.
Cell, vol. 23, issued Mar. 1981, Rozengurt et al, "Melittin Stimulates Na Entry". . . , pp. 781-788.
J. Biol. Chem., vol. 243, No. 23, issued 10 Dec. 1968, Takahashi, "The Reaction of Phenylglyoxal with Arginine . . . ", pp. 6171-6179.
Jaynes, J. M., et al. "In Vitro Cytocidal Effect Of Lytic Peptides On Several Transformed Mammalian Cell Lines", Peptide Research, 2:157-160 (1989).
Jaynes, J. M. "Lytic Peptides Portend An Innovation Age In The Management And Treatment Of Human Disease", Drug News and Perspectives, 3:69-78 (1990).
Akerfeldt, et al. "Synthetic Peptides As Models For Ion Channel Proteins", Acc. Chem. Res., 26:191-197 (1993).
Reed, W. A., et al. "Enhanced In Vitro Growth Of Murine Fibroblast Cells And Preimplantation Embryos Cultured In Medium Supplemented With An Amphipathic Peptide," Molecular Reproduction and Development 31:106-113 (1992).
Arrowood, M. J., et al. "Hemolytic Properties Of Lytic Peptides Active Against The Sporozites Of Cryptosporidium Parvum," J. Protozool. 38:161s-163s (1991).
Jaynes, J. M. et al. "In Vitro Effect Of Novel Lytic Peptides On Plasmodium Falciparum And Trypanosoma Cruzi," Faseb J. 2:2878-2883 (1988).
Graham, M. L. et al. "Cytotoxic Effect Of Amphipathic Cationic Lytic Peptides On Human And Murine Cancer Cell Lines", Proceedings of the American Association for Cancer Research 35:410 (1994).
"Preliminary Experimental Anti-Cancer Activity Of Cecropin B," Proceedings of the American Association for Cancer Research 35:410 (1994).

Patent Family

Document NumberAssigneeInventorsIssue/Pub Date
US5561107 Demeter Biotechnologies, Ltd. Jesse M. Jaynes et al. Oct 1996
US5773413 Demeter Biotechnologies, Ltd. Jesse M. Jaynes et al. Jun 1998